Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.771.545.163.901.57

What is the latest Working Capital/Sales ratio of ORCHID PHARMA ?

The latest Working Capital/Sales ratio of ORCHID PHARMA is 1.77 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.77
Mar20241.54
Mar20235.16
Mar20223.90
Mar20211.57

How is Working Capital/Sales of ORCHID PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.77
14.94
Mar2024 1.54
-70.16
Mar2023 5.16
32.31
Mar2022 3.9
148.41
Mar2021 1.57 -

Other Financial Ratios of ORCHID PHARMA


Compare Working Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,647.0 Cr -1.3% -15.8% -33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.3%

-15.8%

-33.3%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses